Use and composition of buffer formulation with multiple ph values and protein digestion enhancer
Abstract
A composition for enhancing protein digestion is disclosed, which includes at least one acid component, at least one base component and a protein digestion enhancer, wherein the at least one acid component is one selected from a group consisting of an organic acid, a phosphoric acid and a combination thereof, the at least one base component is one selected from a group consisting of an organic base, a phosphate and a combination thereof, the at least one acid component and the at least one base component conjugate with each other to form a buffer formulation, and the protein digestion enhancer is one selected from a group consisting of an ascorbic acid, a salt of the ascorbic acid and a combination thereof.
Claims
exact text as granted — not AI-modified1 - 3 . (canceled)
4 . A composition for enhancing protein digestion, comprising:
at least one acid component being one selected from a group consisting of an organic acid, a phosphoric acid and a combination thereof; at least one base component being one selected from a group consisting of an organic base, a phosphate and a combination thereof, wherein the at least one acid component and the at least one base component conjugate with each other to form a buffer formulation; and a protein digestion enhancer being one selected from a group consisting of an ascorbic acid, a salt of the ascorbic acid and a combination thereof.
5 . A composition as claimed in claim 4 , which is added into a protein nutritional supplement, wherein the protein nutritional supplement is one of a formulated milk powder and an animal feed.
6 . A composition as claimed in claim 4 , wherein the acid component is one selected from a group consisting of a formic acid, an acetic acid, a propionic acid, a butyric acid, a malic acid, a fumaric acid, a lactic acid, a citric acid and the phosphoric acid, and either of the organic base and the phosphate is one of an alkali metal salt and an alkaline earth metal salt.
7 . A composition as claimed in claim 6 , wherein the organic acid is the citric acid, and the organic base is one of a sodium citrate and a potassium citrate.
8 . A composition as claimed in claim 4 , wherein the buffer formulation is evenly mixed with the protein digestion enhancer.
9 . A composition as claimed in claim 4 , wherein the buffer formulation has multiple pHs.
10 . A composition as claimed in claim 4 , wherein the ascorbic acid has a concentration range from 60 ppm to 1000 ppm.
11 . A composition as claimed in claim 4 , wherein the salt of the ascorbic acid is one selected from a group consisting of a sodium salt, a potassium salt, a calcium salt, a magnesium salt and a combination thereof.
12 . A composition as claimed in claim 4 , wherein the composition enhances digestion capability of a pepsin and a trypsin in an environment with a pH of 2-7.5.
13 . A composition as claimed in claim 12 , wherein the composition enhances digestion capability of the pepsin and the trypsin in the environment with the pH of 5-6.
14 . A composition as claimed in claim 4 , wherein the composition is manufactured as one being selected from a group consisting of a powder, a particle, a tablet, a micron-particle, a liquid and a capsule.
15 . A composition as claimed in claim 4 , wherein the ascorbic acid is an L-ascorbic acid.
16 . A method for increasing at least one of digestion and absorption efficacies, the method comprising steps of:
providing a composition including at least one acid component, at least one base component and a protein digestion enhancer, wherein the at least one acid component is one selected from a group consisting of an organic acid, a phosphoric acid and a combination thereof, the at least one base component is one selected from a group consisting of an organic base, a phosphate and a combination thereof, the at least one acid component and the at least one base component conjugate with each other to form a buffer formulation, and the protein digestion enhancer is one selected from a group consisting of an ascorbic acid, a salt of the ascorbic acid and a combination thereof; and administering the composition to one of a human being and an animal.
17 . A method as claimed in claim 16 , wherein the buffer formulation has multiple pHs.
18 . A method as claimed in claim 16 , wherein the buffer formulation steadily sustains an activity of the ascorbic acid when pH >4.
19 . A method as claimed in claim 16 , wherein the acid component is one selected from a group consisting of a formic acid, an acetic acid, a propionic acid, a butyric acid, a malic acid, a fumaric acid, a lactic acid, a citric acid and the phosphoric acid, and either of the organic base and the phosphate is one of an alkali salt and an alkali earth metal salt.
20 . A method as claimed in claim 19 , wherein the organic acid is the citric acid, and the organic base is one of a sodium citrate and a potassium citrate.
21 . A method as claimed in claim 16 , wherein the ascorbic acid has a concentration range from 60 ppm to 1000 ppm.
22 . A method as claimed in claim 16 , wherein the salt of the ascorbic acid is one selected from a group consisting of a sodium salt, a potassium salt, a calcium salt, a magnesium salt and a combination thereof.
23 . A method as claimed in claim 16 , wherein the ascorbic acid is an L-ascorbic acid.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.